Adina Simona Voiculescu, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Artery Obstruction | 18 | 2014 | 219 | 2.870 |
Why?
|
| Hypertension, Renovascular | 10 | 2014 | 116 | 1.690 |
Why?
|
| Ultrasonography, Doppler, Duplex | 9 | 2014 | 198 | 1.090 |
Why?
|
| Kidney Transplantation | 18 | 2016 | 4235 | 1.030 |
Why?
|
| Fistula | 1 | 2021 | 212 | 0.660 |
Why?
|
| Renal Artery | 11 | 2014 | 351 | 0.570 |
Why?
|
| Fibromuscular Dysplasia | 4 | 2014 | 55 | 0.550 |
Why?
|
| Living Donors | 6 | 2009 | 641 | 0.530 |
Why?
|
| Catheterization, Central Venous | 1 | 2021 | 526 | 0.530 |
Why?
|
| Bacteremia | 1 | 2021 | 980 | 0.460 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 1213 | 0.400 |
Why?
|
| Ultrasonography, Doppler, Color | 4 | 2006 | 231 | 0.400 |
Why?
|
| Cytomegalovirus | 1 | 2016 | 756 | 0.380 |
Why?
|
| Renal Dialysis | 4 | 2022 | 1796 | 0.370 |
Why?
|
| Immunocompromised Host | 1 | 2016 | 858 | 0.360 |
Why?
|
| Thrombosis | 2 | 2022 | 2942 | 0.350 |
Why?
|
| Angiography | 6 | 2009 | 1595 | 0.350 |
Why?
|
| Cytomegalovirus Infections | 1 | 2016 | 831 | 0.330 |
Why?
|
| Angioplasty, Balloon | 5 | 2009 | 589 | 0.320 |
Why?
|
| Magnetic Resonance Angiography | 6 | 2014 | 1432 | 0.310 |
Why?
|
| Virus Replication | 1 | 2016 | 2435 | 0.300 |
Why?
|
| Angiography, Digital Subtraction | 6 | 2014 | 335 | 0.300 |
Why?
|
| Plasmapheresis | 1 | 2008 | 206 | 0.290 |
Why?
|
| Immune System Diseases | 1 | 2008 | 256 | 0.260 |
Why?
|
| Iliac Artery | 3 | 2003 | 343 | 0.250 |
Why?
|
| Vascular Diseases | 2 | 2003 | 1161 | 0.240 |
Why?
|
| Renin | 1 | 2006 | 641 | 0.230 |
Why?
|
| Constriction, Pathologic | 3 | 2021 | 1096 | 0.230 |
Why?
|
| Transplants | 1 | 2005 | 206 | 0.210 |
Why?
|
| Renal Veins | 1 | 2002 | 102 | 0.210 |
Why?
|
| Aortic Valve Stenosis | 1 | 2014 | 2001 | 0.200 |
Why?
|
| Kidney | 7 | 2012 | 7048 | 0.190 |
Why?
|
| Hematuria | 1 | 2003 | 233 | 0.190 |
Why?
|
| Postoperative Complications | 9 | 2016 | 15633 | 0.190 |
Why?
|
| Vascular Surgical Procedures | 6 | 2014 | 1489 | 0.190 |
Why?
|
| Aneurysm, False | 1 | 2003 | 255 | 0.180 |
Why?
|
| Histocompatibility Testing | 1 | 2002 | 712 | 0.180 |
Why?
|
| Arteriovenous Fistula | 1 | 2003 | 319 | 0.170 |
Why?
|
| Graft Rejection | 6 | 2006 | 4446 | 0.160 |
Why?
|
| Catheters, Indwelling | 1 | 2021 | 426 | 0.160 |
Why?
|
| Mycophenolic Acid | 3 | 2006 | 349 | 0.160 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2022 | 292 | 0.160 |
Why?
|
| Fibrin | 1 | 2021 | 507 | 0.150 |
Why?
|
| Renal Circulation | 4 | 2009 | 291 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2016 | 3206 | 0.150 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1626 | 0.150 |
Why?
|
| Kidney Function Tests | 4 | 2009 | 679 | 0.130 |
Why?
|
| Immunosuppressive Agents | 4 | 2012 | 4176 | 0.120 |
Why?
|
| Keratoplasty, Penetrating | 2 | 2005 | 144 | 0.110 |
Why?
|
| Creatinine | 7 | 2012 | 1899 | 0.110 |
Why?
|
| Stents | 4 | 2009 | 3179 | 0.110 |
Why?
|
| Renal Insufficiency | 2 | 2009 | 809 | 0.110 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 1303 | 0.110 |
Why?
|
| Nephrectomy | 3 | 2009 | 937 | 0.100 |
Why?
|
| Ultrasonography | 3 | 2021 | 5971 | 0.100 |
Why?
|
| Sensitivity and Specificity | 6 | 2014 | 14665 | 0.100 |
Why?
|
| Family | 1 | 2003 | 3195 | 0.100 |
Why?
|
| Retrospective Studies | 11 | 2022 | 80647 | 0.100 |
Why?
|
| Blood Flow Velocity | 2 | 2022 | 1371 | 0.100 |
Why?
|
| Middle Aged | 28 | 2016 | 220921 | 0.090 |
Why?
|
| Humans | 41 | 2022 | 761596 | 0.090 |
Why?
|
| Follow-Up Studies | 8 | 2016 | 39106 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2003 | 3964 | 0.080 |
Why?
|
| Adult | 20 | 2016 | 221210 | 0.080 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2009 | 133 | 0.080 |
Why?
|
| Lupus Nephritis | 1 | 2012 | 317 | 0.080 |
Why?
|
| Age Factors | 2 | 2002 | 18399 | 0.080 |
Why?
|
| Hemofiltration | 1 | 2008 | 59 | 0.080 |
Why?
|
| Endarterectomy | 1 | 2009 | 196 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2014 | 1096 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2014 | 1468 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2009 | 20568 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2014 | 735 | 0.070 |
Why?
|
| Pain | 1 | 2002 | 5073 | 0.070 |
Why?
|
| Treatment Outcome | 11 | 2022 | 64685 | 0.070 |
Why?
|
| Blood Pressure | 7 | 2014 | 8481 | 0.070 |
Why?
|
| Male | 26 | 2016 | 360846 | 0.070 |
Why?
|
| Germany | 1 | 2009 | 875 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2012 | 2220 | 0.070 |
Why?
|
| Patient Selection | 3 | 2009 | 4244 | 0.070 |
Why?
|
| Hypertension | 1 | 2006 | 8540 | 0.070 |
Why?
|
| Female | 27 | 2016 | 392705 | 0.070 |
Why?
|
| Hypertension, Renal | 1 | 2006 | 135 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2004 | 1516 | 0.060 |
Why?
|
| Histocompatibility | 2 | 2003 | 317 | 0.060 |
Why?
|
| Decision Trees | 1 | 2006 | 504 | 0.060 |
Why?
|
| Saphenous Vein | 1 | 2007 | 516 | 0.060 |
Why?
|
| Captopril | 1 | 2004 | 265 | 0.060 |
Why?
|
| Tissue Donors | 2 | 2005 | 2332 | 0.060 |
Why?
|
| Vascular Patency | 2 | 2022 | 911 | 0.050 |
Why?
|
| Keratitis, Herpetic | 1 | 2003 | 77 | 0.050 |
Why?
|
| Acyclovir | 1 | 2003 | 268 | 0.050 |
Why?
|
| Corneal Transplantation | 1 | 2006 | 321 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2005 | 1496 | 0.050 |
Why?
|
| Urography | 1 | 2003 | 316 | 0.050 |
Why?
|
| Prognosis | 3 | 2014 | 29629 | 0.050 |
Why?
|
| Enalaprilat | 1 | 2000 | 10 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 2 | 2009 | 2178 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2002 | 462 | 0.040 |
Why?
|
| Iopamidol | 1 | 2001 | 186 | 0.040 |
Why?
|
| Incidence | 3 | 2012 | 21355 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2003 | 1178 | 0.040 |
Why?
|
| Recurrence | 4 | 2009 | 8466 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 1972 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2006 | 2643 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2009 | 3359 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2005 | 858 | 0.040 |
Why?
|
| Aneurysm | 1 | 2003 | 337 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2005 | 909 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 2 | 2009 | 2472 | 0.040 |
Why?
|
| Aorta, Abdominal | 1 | 2002 | 625 | 0.040 |
Why?
|
| Aged | 14 | 2009 | 169310 | 0.040 |
Why?
|
| Sirolimus | 1 | 2006 | 1533 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 20100 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2002 | 748 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2001 | 592 | 0.040 |
Why?
|
| Contrast Media | 2 | 2001 | 5307 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 1055 | 0.040 |
Why?
|
| Aneurysm, Ruptured | 1 | 2003 | 464 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2009 | 2791 | 0.040 |
Why?
|
| Lung | 1 | 2016 | 10002 | 0.040 |
Why?
|
| Antihypertensive Agents | 2 | 2004 | 2024 | 0.040 |
Why?
|
| Young Adult | 3 | 2014 | 59260 | 0.030 |
Why?
|
| Time Factors | 7 | 2022 | 39969 | 0.030 |
Why?
|
| Gadolinium | 1 | 2001 | 960 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2009 | 6377 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 4062 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2002 | 1023 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2006 | 4160 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2014 | 42232 | 0.030 |
Why?
|
| Radiography | 4 | 2009 | 6965 | 0.030 |
Why?
|
| Orbivirus | 1 | 1974 | 1 | 0.030 |
Why?
|
| Comorbidity | 1 | 2009 | 10508 | 0.030 |
Why?
|
| Ticks | 1 | 1974 | 70 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2005 | 1924 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 12973 | 0.030 |
Why?
|
| Reoviridae | 1 | 1974 | 162 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2003 | 1418 | 0.030 |
Why?
|
| Ischemia | 1 | 2002 | 1884 | 0.030 |
Why?
|
| Prospective Studies | 6 | 2012 | 54423 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 9001 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2004 | 3575 | 0.020 |
Why?
|
| Acute Disease | 1 | 2002 | 7237 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2004 | 1924 | 0.020 |
Why?
|
| Graft Survival | 1 | 2002 | 3820 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2002 | 2330 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2003 | 3060 | 0.020 |
Why?
|
| Risk Factors | 2 | 2009 | 74213 | 0.020 |
Why?
|
| Proteinuria | 1 | 2012 | 607 | 0.020 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2009 | 42 | 0.020 |
Why?
|
| Kidney Cortex | 1 | 2009 | 169 | 0.020 |
Why?
|
| Child | 2 | 2014 | 80158 | 0.020 |
Why?
|
| Adolescent | 2 | 2014 | 88326 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 14033 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2003 | 6391 | 0.020 |
Why?
|
| Transplantation, Homologous | 2 | 2009 | 4807 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2009 | 58984 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2012 | 6312 | 0.020 |
Why?
|
| Spin Labels | 1 | 2009 | 337 | 0.020 |
Why?
|
| Hydronephrosis | 1 | 2009 | 271 | 0.020 |
Why?
|
| Prednisone | 1 | 2012 | 1563 | 0.020 |
Why?
|
| Syndrome | 1 | 2014 | 3267 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 23996 | 0.020 |
Why?
|
| Vascular Resistance | 2 | 2001 | 930 | 0.020 |
Why?
|
| Urea | 1 | 2009 | 443 | 0.020 |
Why?
|
| Disease Progression | 1 | 2004 | 13510 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2009 | 1122 | 0.020 |
Why?
|
| Fluocortolone | 1 | 2006 | 1 | 0.020 |
Why?
|
| Reoperation | 2 | 2009 | 4303 | 0.020 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2003 | 11 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 1881 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2009 | 2257 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2005 | 778 | 0.010 |
Why?
|
| Reference Values | 1 | 2009 | 4920 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 36426 | 0.010 |
Why?
|
| Virus Activation | 1 | 2003 | 322 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2006 | 8633 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2006 | 1814 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 10766 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 2005 | 1007 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 1757 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2009 | 2884 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2000 | 1379 | 0.010 |
Why?
|
| Herpesvirus 1, Human | 1 | 2003 | 753 | 0.010 |
Why?
|
| Organ Preservation | 1 | 2001 | 382 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2002 | 951 | 0.010 |
Why?
|
| Software | 1 | 2009 | 4434 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2009 | 5079 | 0.010 |
Why?
|
| Europe | 1 | 2001 | 3420 | 0.010 |
Why?
|
| Romania | 1 | 1974 | 92 | 0.010 |
Why?
|
| Animals | 2 | 2004 | 168475 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9469 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 36193 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15843 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 10090 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 12723 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 10212 | 0.000 |
Why?
|